CPR Invest - Megatrends - A EUR - Acc ISIN : LU1734693812

CPR Invest - Megatrends - A EUR - Acc
A(C) - LU1734693812
Asset class: Equities

YTD
As of 25/08/2026
13.34%

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 26/08/2026
€183.65

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 26/08/2026
€285.28M
The investment objective is to outperform global equity markets over a long-term period (minimum of five years) by investing in equity funds or equities that benefit from global thematic trends.

NAVs

NAV from 12/14/2017 to 08/26/2026
Select period
Created with Highcharts 11.4.8CPR Invest - Megatrends - A EUR - AccJan '18Jul '18Jan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '2675100125150175200

Performance

Change in NAV in base 100
FundCPR Invest - Megatrends - A EUR - Acc (83.11% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Megatrends - A EUR - AccBenchmarkJan '18Jul '18Jan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '2650100150200250300
* Rolling performance : for funds that have been launched since less than 1 year or 3 years or 5 years, the performance showed in the table in the 1 year or 3 years or 5 years column is the performance since inception of the fund.

All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.

Past performance does not guarantee future returns. The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.

The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).

The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.
FundCPR Invest - Megatrends - A EUR - Acc (83.11% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Megatrends - A EUR - AccBenchmarkJan '18Jul '18Jan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '2650100150200250300
* Rolling performance : for funds that have been launched since less than 1 year or 3 years or 5 years, the performance showed in the table in the 1 year or 3 years or 5 years column is the performance since inception of the fund.

All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.

Past performance does not guarantee future returns. The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.

The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).

The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.

Portfolio Analysis

Repartition 07/31/2026
Created with Highcharts 11.4.8Values30.7130.7110.5410.549.649.649.399.399.069.068.978.977.747.742.752.752.622.622.502.501.901.901.811.81Portfolio0246810121416182022242628303234Information TechnologyFinancialsHealth CareIndustrialsUnknownCommunication ServicesConsumer DiscretionaryEnergyConsumer StaplesMaterialsReal EstateUtilitiesHighcharts.com

Management commentary

Effective date: 31/07/2026

The month of July 2026 was marked by the end of negotiations and the resumption of hostilities between Iran and the United States. As a result, the Brent barrel price rose sharply in the first part of the month, reaching $100, before slightly declining at the very end of the month to $89. Ultimately, its increase was 22% for the month, the strongest rise since March. The price of gold ended the month almost unchanged. The erratic movement of inflation indices reflects the volatility of oil prices. In the United States, total inflation surprised significantly to the downside for June, at 3.5%, partly thanks to the drop in energy prices that month but also due to a clear and widespread decrease in underlying inflation. Conversely, inflation surprised to the upside in the eurozone in July, at 2.9%, due to the rebound in oil prices.
 

 Several major central banks held their monetary policy committee meetings in July, but none decided to change their interest rate policy. The ECB left its deposit rate unchanged at 2.25% but opened the door to a hike in September. The same applies to the Bank of Japan. For its part, the Fed did not change its key rates but was satisfied with the rise in bond yields since the previous committee, in direct reaction to economic developments. Above all, it confirmed a radical change in its communication regime: it will provide significantly fewer indications than in the past.
 

On the fixed income markets, bond yields rose sharply over the month, largely due to the rebound in oil prices. Ultimately, the US and German 10-year yields climbed by about 30 bps over the month, ending at 4.71% and 3.17% respectively. In Japan, long-term rates increased slightly, with the 10-year rate ending the month at 2.75%. In Europe, credit spreads remained roughly unchanged over the month, staying below the levels that prevailed before the war in Iran.
 

On the equity markets, indices moved in a scattered fashion. The S&P 500 ended the month at roughly the same level (-0.1%), with a clear underperformance in the technology sector, while the Eurostoxx 600 rose by 1.2%. The decline was more significant for the Nikkei (-8.1% for the month) and the MSCI Emerging (-3.3% for the month), due to the overall underperformance of the technology sector. Thus, we cannot speak of a "risk off" in the markets but rather of sector rotation, with a sell-off of the broad AI theme to reposition in other sectors such as banks or healthcare. On the micro side, Q3 2025 results are the best earnings season in Europe in three years, with 55% of companies reporting above expectations, compared to 25% below. The sectors showing the strongest results and upward revisions are banks and tech. European earnings revisions are at their highest level in four years. In the US, 86% of S&P 500 companies beat earnings expectations, which could make it the best reporting season in five years.
 

Regarding the decline in the AI theme, we have identified four reasons. The rise of open source models and token optimization, with concerns that cheaper alternatives may slow the growth of OpenAI or Anthropic. Next, questions about the duration of the memory cycle. Then, financing agreements deemed "circular," where chip manufacturers financially support infrastructures that will later purchase their products. Finally, positioning had become extremely crowded, making semiconductors very vulnerable to any profit-taking. Thus, technical flows remain an important factor in the decline of Tech. Leveraged ETFs generated nearly $19bn in sales via short gamma flows on the Nasdaq and Kospi. The key point is that the correction does not reflect a sudden collapse of fundamentals, but rather the accumulation of several concerns in a sector that has become very crowded.
 

In July, CPR Megatrends is down 2.57% compared to -0.12% for its benchmark index, the MSCI World (EUR). We suffered from the performance of low tracking error themes such as CPR Climate Actions and CPR Social Equities, which fell by -1.62% and -2.28% respectively. But in this context of thematic rotation, it was our positions related to the AI theme that cost the most. CPR AI is down 7.89% and the Amundi Semiconductors ETF by 13.8%. Our "AI Power" basket is down 5.61%, our "Memory" basket is down sharply by 27.79%. We also suffered from our exposure to Renewable Energies, reputedly linked to AI, with KBI Energy Transition down 7.6%. Only our strong exposures to Amundi S&P World Healthcare ETFs and Ishares US Banks partially offset the losses, with respective performances of 0.60% and 2.17%.

Characteristics

General data

Inception date
14/12/2017
First Nav Date
14/12/2017
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs1.85% of the value of your investment per year. This percentage is based on actual costs over the last year.€175.56
Transaction costs0.09% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€8.84
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

15.00% annual outperformance of the reference asset 100% MSCI WORLD NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€8.36

Codification

ISIN code
LU1734693812
Bloomberg code
CPMEGAA LX
Reuters code
LP68460147

Investment Objective

The investment objective is to outperform global equity markets over a long-term period (minimum of five years) by investing in equity funds or equities that benefit from global thematic trends.

Documents

LanguageDocumentsTypeClosing Date
NL
PDF
30/01/2026
PDF
31/01/2026
EN
PDF
31/07/2025
PDF
07/05/2026
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only.
Nothing contained in this site constitutes a solicitation or offer by any member of the Amundi to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". Amundi does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.
The collective inestment scheme (UCITS) has been recognised for public marketing in the Netherlands  by the Authority for The Financial Markets (AFM)